Santoni A - Search Results

1

Reactive oxygen species- and DNA damage response-dependent NK cell activating ligand upregulation occurs at transcriptional levels and requires the transcriptional factor E2F1.

Soriani A, Iannitto ML, Ricci B, Fionda C, Malgarini G, Morrone S, Peruzzi G, Ricciardi MR, Petrucci MT, Cippitelli M, Santoni A. Soriani A, et al. Among authors: santoni a. J Immunol. 2014 Jul 15;193(2):950-60. doi: 10.4049/jimmunol.1400271. Epub 2014 Jun 9. J Immunol. 2014. PMID: 24913980 Free article.

2

Preferential involvement of a phospholipase A2-dependent pathway in CD69-mediated platelet activation.

Testi R, Pulcinelli FM, Cifone MG, Botti D, Del Grosso E, Riondino S, Frati L, Gazzaniga PP, Santoni A. Testi R, et al. Among authors: santoni a. J Immunol. 1992 May 1;148(9):2867-71. J Immunol. 1992. PMID: 1315360

3

Triggering through CD16 or phorbol esters enhances adhesion of NK cells to laminin via very late antigen 6.

Gismondi A, Mainiero F, Morrone S, Palmieri G, Piccoli M, Frati L, Santoni A. Gismondi A, et al. Among authors: santoni a. J Exp Med. 1992 Nov 1;176(5):1251-7. doi: 10.1084/jem.176.5.1251. J Exp Med. 1992. PMID: 1402670 Free PMC article.

4

Soluble and cell-associated IL-2 receptor (IL-2R) after local immunotherapy with recombinant interleukin-2 (rIL-2).

Velotti F, Giuffrida A, Cippitelli M, Stoppacciaro A, Tubaro A, Ruco L, Santoni A. Velotti F, et al. Among authors: santoni a. Pharmacol Res. 1992 Sep;26 Suppl 2:52-3. doi: 10.1016/1043-6618(92)90595-3. Pharmacol Res. 1992. PMID: 1409326 No abstract available.

5

TNF impairs in vivo and in vitro natural killer (NK) susceptibility of B16 melanoma cells.

Palmieri G, Morrone S, Lollini PL, De Giovanni C, Nicoletti G, Nanni P, Frati L, Santoni A. Palmieri G, et al. Among authors: santoni a. Scand J Immunol. 1992 Mar;35(3):279-87. doi: 10.1111/j.1365-3083.1992.tb02860.x. Scand J Immunol. 1992. PMID: 1535986

6

Differential expression of granzyme A and granzyme B proteases and their secretion by fresh rat natural killer cells (NK) and lymphokine-activated killer cells with NK phenotype (LAK-NK).

Velotti F, Palmieri G, D'Ambrosio D, Piccoli M, Frati L, Santoni A. Velotti F, et al. Among authors: santoni a. Eur J Immunol. 1992 Apr;22(4):1049-53. doi: 10.1002/eji.1830220426. Eur J Immunol. 1992. PMID: 1551404

7

Murine monoclonal antibody recognizing a 90-kDa cell-surface determinant selectively lost by multi-drug-resistant variants of CEM cells.

Cianfriglia M, Cenciarelli C, Tombesi M, Barca S, Mariani M, Morrone S, Santoni A, Samoggia P, Alessio M, Malavasi F. Cianfriglia M, et al. Among authors: santoni a. Int J Cancer. 1990 Jan 15;45(1):95-103. doi: 10.1002/ijc.2910450118. Int J Cancer. 1990. PMID: 1688832

8

Human natural killer cells express VLA-4 and VLA-5, which mediate their adhesion to fibronectin.

Gismondi A, Morrone S, Humphries MJ, Piccoli M, Frati L, Santoni A. Gismondi A, et al. Among authors: santoni a. J Immunol. 1991 Jan 1;146(1):384-92. J Immunol. 1991. PMID: 1701798

9

GTP-binding proteins transduce signals generated via human FC gamma receptor IIIA (CD16).

Procopio AD, Paolini R, Vecchio I, Frati L, Santoni A. Procopio AD, et al. Among authors: santoni a. J Immunol. 1991 May 15;146(10):3550-6. J Immunol. 1991. PMID: 1827488

10

In vivo cadmium treatment alters natural killer activity and large granular lymphocyte number in the rat.

Cifone MG, Alesse E, Di Eugenio R, Napolitano T, Morrone S, Paolini R, Santoni G, Santoni A. Cifone MG, et al. Among authors: santoni g, santoni a. Immunopharmacology. 1989 Nov-Dec;18(3):149-56. doi: 10.1016/0162-3109(89)90012-x. Immunopharmacology. 1989. PMID: 2606647

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

536 results

Search Page

Filters